NL-OMON48704招募中4 期
EvaluaTIoN of Clinical and laboratory outcomes of Rivaroxaban in short Bowel syndrome patients dEpending on Long term parenteral nutrition: a prospective cohort study (TINCRBEL study) - TINCRBEL study
Vasculaire Geneeskunde0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •-Diagnosis of short bowel syndrome (<170 cm after Treitz ligamentum) or
- •intestinal malabsorption, diagnosed by an endocrinologist in the AMC
- •- Current use of TPN
- •- Age 18 years or over-
- •- Indication for anticoagulant therapy (DOAC, vitamin K antagonist, heparin)
- •such as stroke prevention in patients with atrial fibrillation, prevention of
- •venous thromboembolic events
排除标准
- •A potential subject who meets any of the following criteria will be excluded
- •from participation in this study- Symptomatic thrombosis at inclusion- Major
- •bleeding defined according to the International Society on Thrombosis and
- •Haemostasis(11) in the 6 months prior to start participation- Contraindication
- •for direct oral anticoagulanto Chronic treatment with NSAID/Cytochrome
- •P450/PgP dependent co-medicationo Severe renal (eGFR<15) or hepatic
- •impairment (Child Pugh score B or C) o Pregnancy or inadequate use of
- •contraception- Gastrectomy or short bowel syndrome < 30 cm after Treitz
- •ligamentum- Medical or psychological condition that would not permit completion
- •of the study or signing of informed consent, including life expectancy less
- •than six months, or unwillingness to sign informed consent;- Non-compliance or
- •inability to adhere to treatment or to the follow-up visits.
研究者
相似试验
尚未招募
不适用
EvaluaTion of Clinical and laboratory outcomes of Rivaroxaban in short Bowel syndrome patients dEpending on Long term parenteral nutrition: a prospective cohort studyNL-OMON28143Amsterdam University Medical Center30
进行中（未招募）
1 期
Evaluation of how well rivaroxaban is absorbed in patients with short bowel syndrom, based on laboratory markers and clinical outcomes such as thrombosis and bleeding.EUCTR2018-001845-15-NLAcademic medical centre, department of internal medicine30
已完成
2 期
A comparative clinico-experimental evaluation of Rasayana Drugs administered orally & by Basti in the management of Madhumeha w. s. r. to Type-II Diabetes MellitusCTRI/2013/05/003705Institute for post graduate teaching and research in Ayurveda Gujarat Ayurved University Jamnagar100
尚未招募
2 期
A clinical trial to study the effects photodynamic therapy in patients with gum diseases.CTRI/2024/06/068905Shweta S Patil
招募中
4 期
Treatment of gum loss in gum disease individuals using animal derived membrane along with patients blood derived substancesCTRI/2024/05/067734kiran choudhary